Abstract: Synthetic derivatives of spiro [pyrrolidinyl-3,3 -oxindole] alkaloids (coerulescine analogues) were investigated as new ligands for aminergic G-protein coupled receptors (GPCRs). The chemical starting point 2 -phenylspiro[indoline-3,3 -pyrrolidin]-2-one scaffold was identified by virtual fragment screening utilizing ligand-and structure based methods. As a part of the hit-to-lead optimization a structure-activity relationship analysis was performed to explore the differently substituted 2 -phenyl-derivatives, introducing the phenylsulphonyl pharmacophore and examining the corresponding reduced spiro [pyrrolidine-3,3 -indoline] scaffold. The optimization process led to ligands with submicromolar affinities towards the 5-HT 6 receptor that might serve as viable leads for further optimization.
Introduction
The recent isolation of naturally occurring and biologically active spiropyrrolidinyl-oxindole alkaloids initiated a significant research on synthetic derivatives [1] , particularly compounds with the spiro[indoline-3,3 -pyrrolidine]-2-one ring system. Spiropyrrolidinyl-oxindole alkaloids were isolated from different species including Gelsemium sempervirens, Aspidosperma, Mitragyna, Ourouparia, Rauwolfia, Vinca species [2] . The most prominent examples are rynchophylline (1), formosanine (2) , coerulescine (3), horsfiline (4) and elacomine (5) that show diverse biological activity ( Figure 1 ). Although these compounds have a common tryptamine derived motif, a ChEMBL-analysis [3] revealed that no representatives have been ever tested against serotonergic targets. Developing ligand-(FrAGs) [4] and structure-based (FrACS) [5] methods for the identification of aminergic receptor ligands we identified 6 as a micromolar 5-hydroxytryptamine receptor 6 (5-HT 6 R) ligand.
The 5-HT 6 R is a member of the Class A G-protein coupled receptors (aminergic family) considered to be a current and promising drug target for the treatment of several central nervous system related indications, such as: cognitive, learning and memory deficits related to Alzheimer's disease [6] , Parkinson's disease [7] and schizophrenia [8] . Chemical similarity to the endogenous agonist serotonin explains the most frequent heteroaromatic ring systems routinely used in 5-HT 6 R ligands that include indoles, indolines, indazoles, pyrrolo [2,3-b] pyridines, pyrazolo [1,5-a] pyridines, [1, 2, 3] -triazolo [1,5-a] pyrimidines and further 5 + 6 condensed N-heterocycles. Pharmacophore based approaches on 5-HT 6 R antagonists are typically focused to the canonical pharmacophore model [9] (Figure 2 ), which is defined as having two hydrophobic rings/ring systems connected by a hydrogen bond acceptor (e.g., sulfonyl, sulfonamide linker). Optionally, a positively ionizable residue is included in one of the hydrophobic sites of the ligands, typically offering an interacting moiety with the D 3.32 The tryptamine derived scaffold of 6 and its alignment with the published 5-HT6R pharmacophore [9] prompted us to explore the structure-activity relationship around the spiropyrrolidinyl-oxindole core. Here we report the results of our hit-to-lead program, which led to an identification of promising 5-HT6R ligands of this chemotype.
Results and Discussion

Identification and Early Structure-Activity Data on Spiro[pyrrolidine-3,3′-oxindole] Derivatives
Fragment libraries containing a couple hundreds or even thousands of small polar molecules are routinely used for hit identification at the early stage of drug discovery. Fragment screening provides diverse chemotypes and significant operational freedom for the further optimization of promising hits. Inspired by these advantages in a recent study we developed a strategy for aminergic focused fragment libraries using a sequential filtering methodology applying ligand-and structure-based scoring functions [4, 5] . The prospective validation was performed on our in-house library of 1183 fragments. A physicochemical-property based scoring, followed by docking the fragments into an ensemble of carefully selected aminergic GPCR X-ray structures (PDB ID: 3PBL, 3RZE, 4IB4, 4IAQ, A further pharmacophore feature might contain an additional intramolecular hydrogen bond donor moiety further stabilizing the binding conformation of the ligands [11] (see Figure 2 ). Selectivity among other aminergic GPCR's was shown [12] to be accessible through omitting the positively ionizable group in the 5-HT6R antagonists. Bis(hetero)arylsulphonyl-and sulfonamide substituents also contribute to 5-HT6R affinity and selectivity. The tryptamine derived scaffold of 6 and its alignment with the published 5-HT6R pharmacophore [9] prompted us to explore the structure-activity relationship around the spiropyrrolidinyl-oxindole core. Here we report the results of our hit-to-lead program, which led to an identification of promising 5-HT6R ligands of this chemotype.
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(a) (b) 
Hit-to-Lead Optimization of Spiro[pyrrolidine-3,3 -oxindoles]
Detailed elaboration of the spiro[pyrrolidine-3,3 -oxindole] scaffold required a viable synthesis strategy for the preparation of designed analogues. The first, conventional approach is based on an intramolecular Mannich-reaction used in case of several alkaloids including (±)-horsfiline (4) [18] and Spirotryprostatin B [19] . An alternative approach is the oxidative reaction of tryptolines induced by tert-butyl hypochlorite, N-bromosuccinimide, N-chlorosuccinimide, sodium tungstate, lead tetraacetate, or osmium tetroxide [20, 21] . The reaction is completed by the subsequent elimination of water that finally results in the reorganization of the ring system to spiro[pyrrolidine-3,3 -oxindoles] (Scheme 1).
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Detailed elaboration of the spiro[pyrrolidine-3,3′-oxindole] scaffold required a viable synthesis strategy for the preparation of designed analogues. The first, conventional approach is based on an intramolecular Mannich-reaction used in case of several alkaloids including (±)-horsfiline (4) [18] and Spirotryprostatin B [19] . An alternative approach is the oxidative reaction of tryptolines induced by tert-butyl hypochlorite, N-bromosuccinimide, N-chlorosuccinimide, sodium tungstate, lead tetraacetate, or osmium tetroxide [20, 21] . The reaction is completed by the subsequent elimination of water that finally results in the reorganization of the ring system to spiro[pyrrolidine-3,3′-oxindoles] (Scheme 1). Further, sophisticated approaches such as [1, 3] -dipolar cycloaddition reactions of azomethine ylides [22] , radical cyclization by AIBN [23] , intramolecular Heck reaction [24] and asymmetric nitroolefination of oxindoles [25] are also available, however, used less frequently.
For the effective exploration of the structure-activity relationship we need a feasible and universal approach with acceptable functional group tolerance and high variability around the spirooxindole core. Considering the requirements of the early stage optimization program we aimed a synthesis strategy that Further, sophisticated approaches such as [1, 3] -dipolar cycloaddition reactions of azomethine ylides [22] , radical cyclization by AIBN [23] , intramolecular Heck reaction [24] and asymmetric nitroolefination of oxindoles [25] are also available, however, used less frequently.
For the effective exploration of the structure-activity relationship we need a feasible and universal approach with acceptable functional group tolerance and high variability around the spiro-oxindole core. Considering the requirements of the early stage optimization program we aimed a synthesis strategy that Following this synthesis strategy, tryptamine (23) was used as a starting material for the synthesis of the common intermediate tryptoline (25) . The Pictet-Spengler condensation reaction was performed by glyoxylic acid-monohydrate in aqueous medium [35] . The crude acid intermediate 24 was decarboxylated in refluxing concentrated hydrochloric acid affording the tetrahydro-β-carboline. The first synthetic route depicted in Scheme 3 starts with the N-acylation of the tryptoline (25) . The application of Cbz (carboxybenzyl) [36] protecting group was necessary for two reasons: 1. achieve the sulfonylation at the oxindol-nitrogen, 2. the spiro-rearrangement reaction is not occurring in case of unsubstituted pyrido-nitrogen. N-chlorosuccinimide [37] was used in the first experiments as halogenating reagent, providing the Cbz-protected spiro[pyrrolidine-3,3′-oxindole]. The Following this synthesis strategy, tryptamine (23) was used as a starting material for the synthesis of the common intermediate tryptoline (25) . The Pictet-Spengler condensation reaction was performed by glyoxylic acid-monohydrate in aqueous medium [35] . The crude acid intermediate 24 was decarboxylated in refluxing concentrated hydrochloric acid affording the tetrahydro-β-carboline. The first synthetic route depicted in Scheme 3 starts with the N-acylation of the tryptoline (25) . The application of Cbz (carboxybenzyl) [36] protecting group was necessary for two reasons: 1. achieve the sulfonylation at the oxindol-nitrogen, 2. the spiro-rearrangement reaction is not occurring in case of unsubstituted pyrido-nitrogen. N-chlorosuccinimide [37] was used in the first experiments as halogenating reagent, providing the Cbz-protected spiro[pyrrolidine-3,3 -oxindole]. The phenylsulfonylation was performed either by using lithium-hexamethyl disilazane [38] and sodium hydride [39] as deprotonating agents and acid scavengers. Finally, the deprotection of the Cbz-group by hydrogenation [40] resulted in the desired 1-(phenylsulfonyl)spiro[indoline-3,3 -pyrrolidin]-2-one (17) compound. Following an alternative way, the more basic pyrido-nitrogen of tryptoline 29 might be first sulfonylated [41] followed by the N-bromosuccinimide assisted spiro-cyclization to 18 [42] .
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Compounds 17 and 18 showed improved selectivity towards the 5-HT6R (Table 3) as compared to the non-sulfonylated 2′-phenyl derivatives, investigated in the first batch (compounds 15-24) , however, no improvement in the binding affinity was detected. Facilitating the potency optimization, we followed the classical 5-HT6R pharmacophore pattern and tried to remove the polar interacting hydrogen bond acceptor feature in the oxindole ring of 17. For better understanding of the indole, indoline and oxindole-related chemical space of known 5-HT6R ligands we collected all compounds, with at least 0.1 µM activity towards h5-HT6R from the ChEMBL database.
Substructure filtering by the query of 30 ( Figure 4 ) revealed that altogether 3 examples were found for oxindoles, as 5-HT6R ligands. All hits belong to the 3′-phenylspiro[indoline-3,2′-thiazolidine]-2,4′-dione scaffold 31 that was identified by Hostetler et al. [43] . Searching for the 1-(phenylsulfonyl) indoline scaffold 32, 27 actives were found with the structure 33. Out of the 27 active molecules 4 possess a positive ionizable moiety built upon the phenyl side of the sulfonyl and all of the remaining examples are equipped by the classical tryptamine-type amine feature. Searching by Facilitating the potency optimization, we followed the classical 5-HT6R pharmacophore pattern and tried to remove the polar interacting hydrogen bond acceptor feature in the oxindole ring of 17. Facilitating the potency optimization, we followed the classical 5-HT 6 R pharmacophore pattern and tried to remove the polar interacting hydrogen bond acceptor feature in the oxindole ring of 17. For better understanding of the indole, indoline and oxindole-related chemical space of known 5-HT 6 R ligands we collected all compounds, with at least 0.1 µM activity towards h5-HT 6 R from the ChEMBL database.
Substructure filtering by the query of 30 ( Figure 4 ) revealed that altogether 3 examples were found for oxindoles, as 5-HT 6 R ligands. All hits belong to the 3 -phenylspiro[indoline-3,2 -thiazolidine]-2,4 -dione scaffold 31 that was identified by Hostetler et al. [43] . Searching for the 1-(phenylsulfonyl) indoline scaffold 32, 27 actives were found with the structure 33. Out of the 27 active molecules 4 possess a positive ionizable moiety built upon the phenyl side of the sulfonyl and all of the remaining examples are equipped by the classical tryptamine-type amine feature. Searching by the 1-(phenylsulfonyl)indole 34 query resulted in 397 examples with the structure 35. The structures were analyzed based on the chain-length distance between the 3-carbon of the indole ring and the positive ionizable basic nitrogen atom, if any. We found 20 examples representing indoles with attached basic nitrogen (all tertiary amines). Only five compounds were identified with a single methylene linker out of which 2 were primary amines and 3 were tertiary amines. The largest part of the with structure 34 contains ethylene linker (201 examples out of 397) of which 123 were tertiary amines, 51 were secondary amines and 19 were primary amines. Much less compounds have 3 atom long linkage, 54 examples were identified, with 21 tertiary amines and 33 secondary amines and no primary amines. No ligands were found with basic nitrogen's being further than 3 atoms from the indole core.
To conclude, we have aimed to synthesize different 1-(phenylsulfonyl)indolines (scaffold 32), being substituted in the 1 -pyrrolidine nitrogen with either basic-nitrogen containing, or lipophilic groups, presented in Scheme 4-compounds 39a-b. Based on these considerations, first we benzylated [44] the tryptoline (25) to afford 36a, further converting it to the corresponding spiro-derivative [45] 37a. The reduction of the oxindole oxo-group was performed by applying borane-tetrahydrofuran complex in refluxing absolutized tetrahydrofuran [46] . It was an important observation, that the reduction step has to precede the sulfonylation, to avoid the formation of side products when treating the sulfonamide with the boronic reagent. The phenyl-sulfonylated product 39a was afforded either by applying LiHMDS [38] or trietylamine/dimethylaminopyridine [47] reagents. The pyridine-4-ylmethyl derivative (39b) was synthesized based on the same route, however, as a first step, the tryptoline (25) was treated with 4-chloromethylpyridine [48, 49] . To conclude, we have aimed to synthesize different 1-(phenylsulfonyl)indolines (scaffold 32), being substituted in the 1′-pyrrolidine nitrogen with either basic-nitrogen containing, or lipophilic groups, presented in Scheme 4-compounds 39a-b. Based on these considerations, first we benzylated [44] the tryptoline (25) to afford 36a, further converting it to the corresponding spiro-derivative [45] 37a. The reduction of the oxindole oxo-group was performed by applying borane-tetrahydrofuran complex in refluxing absolutized tetrahydrofuran [46] . It was an important observation, that the reduction step has to precede the sulfonylation, to avoid the formation of side products when treating the sulfonamide with the boronic reagent. The phenyl-sulfonylated product 39a was afforded either by applying LiHMDS [38] or trietylamine/dimethylaminopyridine [47] reagents. The pyridine-4-ylmethyl derivative (39b) was synthesized based on the same route, however, as a first step, the tryptoline (25) was treated with 4-chloromethylpyridine [48, 49] .
We also intended to examine the effect of only transforming our initial test compound 17 to the corresponding reduced indoline, however the debenzylation step of 39a afforded unexpected products (Scheme 5, 40a and 40b). In case, when methanol was applied as solvent for the debenzylation by catalytic hydrogenation, a methylated product 40a has formed and respectively, the use of ethanol afforded an ethyl-alkylated derivative 40b. However, both the alkylated derivatives showed some improvement of binding affinity to reach the low micromolar range, the compound possessing the biggest lipophilic, bulky group 43a has produced the best, submicromolar binding affinity, with both selectivity against the other closely related serotonergic targets (Table 4) . We also intended to examine the effect of only transforming our initial test compound 17 to the corresponding reduced indoline, however the debenzylation step of 39a afforded unexpected products (Scheme 5, 40a and 40b). In case, when methanol was applied as solvent for the debenzylation by catalytic hydrogenation, a methylated product 40a has formed and respectively, the use of ethanol afforded an ethyl-alkylated derivative 40b. However, both the alkylated derivatives showed some improvement of binding affinity to reach the low micromolar range, the compound possessing the biggest lipophilic, bulky group 43a has produced the best, submicromolar binding affinity, with both selectivity against the other closely related serotonergic targets (Table 4) . However, both the alkylated derivatives showed some improvement of binding affinity to reach the low micromolar range, the compound possessing the biggest lipophilic, bulky group 43a has produced the best, submicromolar binding affinity, with both selectivity against the other closely related serotonergic targets (Table 4) . However, both the alkylated derivatives showed some improvement of binding affinity to reach the low micromolar range, the compound possessing the biggest lipophilic, bulky group 43a has produced the best, submicromolar binding affinity, with both selectivity against the other closely related serotonergic targets (Table 4 ). However, both the alkylated derivatives showed some improvement of binding affinity to reach the low micromolar range, the compound possessing the biggest lipophilic, bulky group 43a has produced the best, submicromolar binding affinity, with both selectivity against the other closely related serotonergic targets (Table 4 ). The submicromolar affinity of 39a prompted us investigating the substituent vectors at both the benzylic and the phenylsulfonyl rings by walking fluorine substituents around. This methodology, often referred as fluoro-scan has been used effectively for the identification of sites tolerant to functionalization. In particular, fluoro-scan explores the impact of enhanced lipophilicity, H-bonding and/or filling a small pocket [50] . In case of the N′-benzylic substitution [13] pattern, 2-, 3-and 4-fluorobenzylchlorides were used as alkylating agents in order to synthesize the corresponding fluorinated indolines (Scheme 6, 44a-c). The submicromolar affinity of 39a prompted us investigating the substituent vectors at both the benzylic and the phenylsulfonyl rings by walking fluorine substituents around. This methodology, often referred as fluoro-scan has been used effectively for the identification of sites tolerant to functionalization. In particular, fluoro-scan explores the impact of enhanced lipophilicity, H-bonding and/or filling a small pocket [50] . In case of the N′-benzylic substitution [13] pattern, 2-, 3-and 4-fluorobenzylchlorides were used as alkylating agents in order to synthesize the corresponding fluorinated indolines (Scheme 6, 44a-c). The submicromolar affinity of 39a prompted us investigating the substituent vectors at both the benzylic and the phenylsulfonyl rings by walking fluorine substituents around. This methodology, often referred as fluoro-scan has been used effectively for the identification of sites tolerant to functionalization. In particular, fluoro-scan explores the impact of enhanced lipophilicity, H-bonding and/or filling a small pocket [50] . In case of the N -benzylic substitution [13] pattern, 2-, 3-and 4-fluorobenzylchlorides were used as alkylating agents in order to synthesize the corresponding fluorinated indolines (Scheme 6, 44a-c).
The submicromolar affinity of 39a prompted us investigating the substituent vectors at both the benzylic and the phenylsulfonyl rings by walking fluorine substituents around. This methodology, often referred as fluoro-scan has been used effectively for the identification of sites tolerant to functionalization. In particular, fluoro-scan explores the impact of enhanced lipophilicity, H-bonding and/or filling a small pocket [50] . In case of the N′-benzylic substitution [13] pattern, 2-, 3-and 4-fluorobenzylchlorides were used as alkylating agents in order to synthesize the corresponding fluorinated indolines (Scheme 6, 44a-c). The substitution of benzylic ring with fluorine caused a minor decrease in affinity, thus has shown, that growing towards this direction is not beneficial (Table 5 ). On the other hand, however, some improvement in the selectivity was observed.
The corresponding fluorophenylsulfonyl derivatives 46a-c were synthesized from compound 38a intermediate, previously synthesized (Scheme 7).
The alternative growing direction towards the phenylsulfonyl ring (compounds 46a-c) showed improvement in the affinities (see Table 6 ), compared to the results of 39a, also retaining the good selectivity against the 5-HT7 subtype. These data suggest, that position 2 of the phenylsulfonyl group of 46a is beneficial and therefore it is worth to explore this vector during the forthcoming lead optimization program, Scheme 6. Fluoro-scan of the N -benzyl direction.
The substitution of benzylic ring with fluorine caused a minor decrease in affinity, thus has shown, that growing towards this direction is not beneficial (Table 5 ). On the other hand, however, some improvement in the selectivity was observed. The alternative growing direction towards the phenylsulfonyl ring (compounds 46a-c) showed improvement in the affinities (see Table 6 ), compared to the results of 39a, also retaining the good selectivity against the 5-HT 7 subtype. These data suggest, that position 2 of the phenylsulfonyl group of 46a is beneficial and therefore it is worth to explore this vector during the forthcoming lead optimization program. 
Binding Mode Analysis of the Optimized 5-HT6R Ligand
We have performed a docking analysis of the 1′-benzyl-1-((2-fluorophenyl)sulfonyl)-spiro [indoline-3,3′-pyrrolidine] (46a) 5-HT6R antagonist using the receptor model reported earlier [15] . Docking of 46a by Schrödinger-Glide either with, or without applying any constraints (requiring hydrogen bonding with both Asn288 6.55 and/or Ser193 5.43 ) resulted in consistent docking poses inside the orthosteric binding pocket ( Figure 5) . 
Binding Mode Analysis of the Optimized 5-HT 6 R Ligand
We have performed a docking analysis of the 1 -benzyl-1-((2-fluorophenyl)sulfonyl)-spiro[indoline-3, 3 -pyrrolidine] (46a) 5-HT 6 R antagonist using the receptor model reported earlier [15] . Docking of 46a by Schrödinger-Glide either with, or without applying any constraints (requiring hydrogen bonding with both Asn288 6.55 and/or Ser193 5.43 ) resulted in consistent docking poses inside the orthosteric binding pocket ( Figure 5 ). [15] . Docking of 46a by Schrödinger-Glide either with, or without applying any constraints (requiring hydrogen bonding with both Asn288 6.55 and/or Ser193 5.43 ) resulted in consistent docking poses inside the orthosteric binding pocket ( Figure 5 ). The indoline core occupies the primary hydrophobic cavity of the binding pocket (formed by Trp281 6.48 , Phe284 6.51 , Phe285 6.52 ), while the protonated quaternary pyrrolidine-nitrogen is oriented towards the conserved Asp106 3.32 , forming a well-established hydrogen bond. The phenyl-sulfonyl moiety of 46a is sitting at a secondary hydrophobic cleft defined by Val107 3.33 , Ala157 4.56 , Leu160 4.59 , Pro160 4.60 and Leu164 4.63 , positioning the sulfonyl-linker as hydrogen-bond acceptor against Ser193 5.43 and Asn288 6.55 . Interestingly, the fluorine atom as hydrogen bond acceptor is offering a possible polar interaction with the Asn288 6.55 residue, underlining the preference of the ortho-substitution at the phenyl-sulfonyl ring.
Binding Mode Analysis of the Optimized 5-HT6R Ligand
We have performed a docking analysis of the 1′-benzyl-1-((2-fluorophenyl)sulfonyl)-spiro [indoline-3,3′-pyrrolidine] (46a) 5-HT6R antagonist using the receptor model reported earlier
Conclusions
The structure-activity relationship around the original spiropyrrolidinyl-oxindole hit (6) was first investigated using the "SAR-by-catalog" approach that resulted in some moderate improvement in affinity and a low level of selectivity. Therefore, we decided to explore the novel 5-HT 6 R chemotype by a more conventional medicinal chemistry strategy. A synthetic tree (summarized in Scheme 8) of the synthesized oxindoles and indoles was elaborated starting from the core tryptoline intermediate (25) .
The removal of the bulky lipophilic site at the 2 -position of the pyrrolidine ring and insertion of the classical phenylsulfonyl part resulted in notable selectivity across the serotoninergic GPCR panel of 4 receptors. The next optimization step was analyzing the chemistry of known indole, indoline and oxindole-based 5-HT 6 R inhibitors in ChEMBL. We have synthesized different 1-(phenylsulfonyl) indolines, being substituted in the 1 -pyrrolidine nitrogen with either basic-nitrogen containing, or lipophilic groups. As a result, 1 -benzyl-1-(phenylsulfonyl) spiro[indoline-3,3 -pyrrolidine] (39a) and its corresponding 2-, 3-substituted analogues 46a-b were identified as 5-HT 6 R starting points. This 
Materials and Methods
All chemical reagents used were purchased from commercial chemical suppliers. The NMR experiments were performed at 500 MHz ( 1 H) on a Varian VNMR SYSTEM spectrometer. Chemical shifts are referenced to the residual solvent signals, 2.50 ppm for 1 H in DMSO-d6 and 7.28 ppm for 1 H in CDCl3. The MS measurements were performed on Shimadzu LCMS2020 LC/MS system. Flash 
All chemical reagents used were purchased from commercial chemical suppliers. The NMR experiments were performed at 500 MHz ( 1 H) on a Varian VNMR SYSTEM spectrometer. Chemical shifts are referenced to the residual solvent signals, 2.50 ppm for 1 H in DMSO-d 6 and 7.28 ppm for 1 H in CDCl 3 . The MS measurements were performed on Shimadzu LCMS2020 LC/MS system. Flash chromatography was performed using Teledyne ISCO CombiFlash Lumen+ Rf. Purifications by preparative-HPLC were performed with Hanbon NS4205 Binary high pressure semi-preparative HPLC. Thin-layer chromatography was performed on TLC Silica Gel 60 F254. High resolution mass spectrometric measurements were performed using a Q-TOF Premier mass spectrometer (Waters Corporation, Milford, MA, USA) in positive electrospray ionization mode. Compounds 7-16 were purchased from Mcule Inc. (27) To the solution of benzyl 3,4-dihydro-1H-pyrido [3,4-b] indole-2(9H)-carboxylate (26) (918 mg, 3 mmol) in 10 mL tetrahydrofuran was added 10 mL distilled water and triethylamine (0.436 mL, 3.15 mmol, 1.05 equiv.) at room temperature. Afterwards N-chlorosuccinimide (431 mg, 3.24 mmol, 1.08 equiv.) was added at 0 • C in portions. The reaction mixture was stirred for 1.5 h at room temperature. The reaction mixture was diluted with 10 mL brine and was extracted using 2 × 10 mL ethyl acetate. The combined organic phases were dried over sodium-sulfate, filtered and evaporated under reduced pressure. The crude material was purified using flash chromatography (gradient: dichloromethane: methanol 0% to 5% methanol) to give 27 as a yellow solid. Yield: 399 mg (41%). After stirring the reaction mixture at room temperature for 0.5 h, benzenesulfonyl chloride (0.076 mL, 0.596 mmol, 1.1 equiv.) was added dropwise at 0 • C. The reaction mixture was stirred overnight at room temperature, then it was quenched by 10 mL brine and was extracted using ethyl acetate (2 × 10 mL). The collected organic phases were dried using sodium sulfate, filtered and evaporated under reduced pressure. The crude product was purified using flash chromatography (gradient: hexane: ethyl acetate 0% to 20%) to afford 28 as a colorless solid. Yield: 94 mg (38%).
(2) Procedure Using Lithium-Hexamethyl-Disilazane
To the solution of benzyl 2-oxospiro[indoline-3,3 -pyrrolidine]-1 -carboxylate (27) (161 mg, 0.5 mmol) and benzenesulfonyl chloride (0.076 mL, 0.6 mmol, 1.2 equiv.) in 5 mL anhydrous tetrahydrofuran was added lithiumhexamethyl-disilazane (1M in THF, 0.85 mL, 0.85 mmol, 1.7 equiv.) at 0 • C and the reaction mixture was stirred at this temperature for 0.5 h. After quenching the reaction by 10 mL brine, the reaction mixture was extracted using ethyl acetate (2 × 10 mL) and the collected organic phases were dried over sodium sulfate, filtered and evaporated under reduced pressure. The crude product was purified using flash chromatography (gradient: hexane: ethyl acetate 0% to 20%) to give 28 as a white solid. Yield: 230 mg (99%). (18) To the solution of 2-(phenylsulfonyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b] indole (29) (312 mg, 1 mmol) in tetrahydrofuran: water (10:10 mL) was added 10 mL glacial acetic acid at 0 • C. N-bromosuccinimide (178 mg, 1 mmol, 1 equiv.) was added slowly in portions at 0 • C. The reaction mixture was stirred for 1.5 h at 0 • C. Afterwards the reaction was quenched at 0 • C by 10 mL concentrated sodium-carbonate solution and was stirred for 0.5 h, allowing to warm up to room temperature. The mixture was extracted using ethyl acetate (2 × 10 mL). The combined organic phases were washed with concentrated sodium-hydrogen carbonate (2 × 10 mL) and by brine (2 × 10 mL). The organic phases were dried over sodium-sulfate, filtered and evaporated under reduced pressure. The crude product was purified using flash chromatography (gradient: hexane: ethyl acetate 0% to 20% ethyl acetate) to afford 18 as a colorless solid. Yield: 180 mg (55%). To the solution of 1 -benzylspiro[indoline-3,3 -pyrrolidin]-2-one (37a) (500 mg, 1.7985 mmol) in 15 mL absolutized tetrahydrofuran was added borane/tetrahydrofuran (1M) complex solution (4.495 mL, 4.495 mmol, 2.5 equiv.) and the reaction mixture was refluxed overnight. The reaction was allowed to cool down to room temperature and was quenched using 30 mL concentrated ammonium-chloride solution and was stirred for 20 min. Afterwards, 20 mL ethyl acetate was used for extraction. The combined organic phases were dried over sodium-sulfate, filtered and evaporated under reduced pressure to afford 400 mg 38a, used as a crude product in the further steps without purification. To the solution of crude 1 -benzylspiro[indoline-3,3 -pyrrolidine] (38a) (400 mg 1.513 mmol) (in anhydrous dichloromethane was added triethylamine (0.419 mL, 3.03 mmol, 2 equiv.) and N,N-dimethylpyridin-4-amine (10 mg, 0.076 mmol, 0.5 equiv.) at room temperature. Afterwards benzenesulfonyl chloride (0.203 mL, 1.59 mmol, 1.05 equiv.) was added to the solution at 5 • C. The reaction mixture was stirred at room temperature overnight. The reaction was quenched using 10 mL 10% HCl solution and was extracted by 10 mL dichloromethane. The dichloromethane phase was collected and dried over sodium-sulfate. The drying agent was filtered-off and the solution was evaporated under reduced pressure. The crude product was purified by flash chromatography to afford 39a as yellow oil. Yield: 621 mg (85% calculated to 37a). 1 H-NMR (500 MHz, DMSO-d 6 ) δ ppm 7.73 (d, J = 7.6 Hz, 2H, phenyl-sulfonyl H-2", phenyl-sulfonyl H-6"), 7.58 (t, J = 7.6 Hz, 1H, H-6), 7.46 (t, J = 7.9 Hz, 3H, phenyl-sulfonyl H-3", phenyl-sulfonyl H-4", phenyl-sulfonyl H-5"), 7.31 (t, J = 7.6 Hz, 2H, phenyl-sulfonyl H-3", phenyl-sulfonyl H-5"), 7.27-7.21 (m, 5H, benzyl H-1-5), 7.05 (t, J = 7. To the solution of the crude 2-(pyridin-4-ylmethyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b] indole (36b) (812 mg) in tetrahydrofuran:water (10:10 mL) was added 10 mL glacial acetic acid at 0 • C. N-bromosuccinimide (549 mg, 3.0874 mmol) was added slowly in portions at 0 • C. The reaction mixture was stirred for 1.5 h at 0 • C. Afterwards the reaction was quenched at 0 • C by 20 mL concentrated sodium-carbonate solution and was stirred for 0.5 h, allowing to warm up to room temperature. The mixture was extracted using ethyl-acetateethyl acetate (2 × 10 mL). The combined organic phases were washed with concentrated sodium-hydrogen carbonate (2 × 10 mL) and by brine (2 × 10 mL). The organic phases were dried over sodium-sulfate, filtered and evaporated under reduced pressure. The crude product was purified using flash chromatography (gradient: dichloromethane: methanol 0% to 10% methanol) to afford 37b as a yellow solid. Yield: 293 mg (35% calculated to 25). 1 To the solution of 1 -(pyridin-4-ylmethyl)spiro[indoline-3,3 -pyrrolidin]-2-one (37b) (289 mg, 1.05 mmol) in 10 mL anhydrousdry tetrahydrofuran was added borane/tetrahydrofuran (1 M) complex solution (2.63 mL, 2.63 mmol, 2.5 equiv.) and the reaction mixture was refluxed overnight. The reaction was allowed to cool down to room temperature and was quenched using 15 mL concentrated ammonium-chloride solution and was stirred for 20 min. Afterwards, 10 mL ethyl acetate was used for extraction. The combined organic phases were dried over sodium-sulfate, filtered and evaporated under reduced pressure to afford 292 mg 38b, used as a crude product in the further steps without purification. To the solution of crude 1 -(pyridin-4-ylmethyl)spiro[indoline-3,3 -pyrrolidine] (38b) (0.292 mg) in 5 mL anhydrous dichloromethane was added triethylamine (0.307 mL, 2.22 mmol) and N,N-dimethylpyridin-4-amine (6.8 mg, 0.0555 mmol) at room temperature. Afterwards benzenesulfonyl chloride (204 mg, 1.161 mmol) was added to the solution at 5 • C. The reaction mixture was stirred at room temperature overnight. The reaction was quenched using 10 mL 10% HCl solution and was extracted by 5 mL dichloromethane. The dichloromethane phase was collected and dried over sodium-sulfate. The drying agent was filtered-off and the solution was evaporated under reduced pressure. The crude product was purified by flash chromatography to afford 39b as yellow solid. Yield: 0.003 mg. The solution of 1 -benzyl-1-(phenylsulfonyl)spiro[indoline-3,3 -pyrrolidine] (39a) (2 mg, 0.495 mmol) in 5 mL methanol was filled into an autoclave. Palladium (10%) on charcoal (100 mg, 5 w/w %) was added to the solution and reaction was stirred overnight under 5 bar hydrogen atmosphere at 50 • C. The reaction mixture was filtered through a pad of Celite and was evaporated under reduced pressure. The crude residual was purified by flash chromatography (gradient: dichloromethane: methanol 0% to 10% methanol) to afford 40a as a colorless solid. Yield: 37 mg (23%). 1 H-NMR (500 MHz, DMSO-d 6 ) δ ppm 7.79 (d, J = 7.5 Hz, 2H, phenyl-sulfonyl ArH-2", phenyl-sulfonyl ArH-6"), 7.66 (t, J = 7.2 Hz, 1H, phenyl-sulfonyl ArH-4"), 7.56 (t, J = 7.9 Hz, 2H, phenyl-sulfonyl ArH-3", phenyl-sulfonyl ArH-5"), 7.48 (d, J = 7.9 Hz, 1H, ArH-7), 7.22 (m, 2H, ArH-4, H-6), 7.03 (t, J = 7. The solution of 1 -benzyl-1-(phenylsulfonyl)spiro[indoline-3,3 -pyrrolidine] (39a) (100 mg, 0.2475 mmol) in 5 mL methanol was filled into an autoclave. Palladium (10%) on charcoal (500 mg, 5 w/w %) was added to the solution and reaction was stirred overnight under 5 bar hydrogen atmosphere at 50 • C. The reaction mixture was filtered through a pad of Celite and was evaporated under reduced pressure. ) or CHO-K1 cells with plasmid containing the sequence coding for the human serotonin 5-HT 2A receptor (PerkinElmer) were maintained at 37 • C in a humidified atmosphere with 5% CO 2 and were grown in Dulbeco's Modifier Eagle Medium containing 10% dialysed fetal bovine serum and 500 µg/mL G418 sulphate. For membranes preparations, cells were subcultured in 150 cm 2 flasks, grown to 90% confluence, washed twice with prewarmed to 37 • C phosphate buffered saline (PBS) and were pelleted by centrifugation (200 g) in PBS containing 0.1 mM EDTA and 1 mM dithiothreitol. Prior to membrane preparations pellets were stored at −80 • C.
Radioligand Binding Assays
Cell pellets were thawed and homogenized in 10 volumes of assay buffer using an Ultra Turrax tissue homogenizer and centrifuged twice at 35,000 g for 20 min at 4 • C, with incubation for 15 min at 37 • C in between. The composition of the assay buffers was as follows: for 5-HT 1A R: 50 mM Tris-HCl, 0.1 mM EDTA, 4 mM MgCl 2 , 10 µM pargyline and 0.1% ascorbate; for 5-HT 2A R: 50 mM Tris-HCl, 0.1 mM EDTA, 4 mM MgCl 2 and 0.1% ascorbate; for 5-HT 6 R: 50 mM Tris-HCl, 0.5 mM EDTA and 4 mM MgCl 2 , for 5-HT 7b R: 50 mM Tris-HCl, 4 mM MgCl 2 , 10 µM pargyline and 0.1% ascorbate. All assays were incubated in a total volume of 200 µL in 96-well microtiter plates for 1 h at 37 • C, except for 5-HT 1A R and 5-HT 2A R which were incubated at room temperature for 1 h and 1.5 h respectively. The process of equilibration is terminated by rapid filtration through Unifilter plates with a 96-well cell harvester and radioactivity retained on the filters was quantified on a Microbeta plate reader (PerkinElmer).
For displacement studies the assay samples contained as radioligands: 2.5 nM Non-specific binding is defined with 10 µM of 5-HT in 5-HT 1A R and 5-HT 7 R binding experiments, whereas 10 µM of chlorpromazine or 10 µM of methiothepine were used in 5-HT 2A R and 5-HT 6 R assays, respectively. Each compound was tested in triplicate at 7-8 concentrations (10 −11 -10 −4 M). The inhibition constants (K i ) were calculated from the Cheng-Prusoff equation [47] . Results were expressed as means of at least three separate experiments (SD ≤ 24%).
Docking Procedure
The homology model of h-5HT 6 R [15] was prepared for docking experiment my Schrödinger's Protein Preparation Wizard by default settings for protomer-state optimization and restrained minimization by OPLS_2005 force field. Single precision docking was performed with Schrödinger's Glide by default settings. The ligand (46a) was prepared for docking by Schrödinger's LigPrep, generating possible ionization states (at pH range of 7.0 ± 2.0), tautomers and stereoisomers. Constrained docking was set to two required interactions (at least 1 match): hydrogen bond formed with Asn288 6.55 and/or hydrogen bond formed with Ser193 5.43 .
